Literature DB >> 14572482

Long-term epidemiological survey of Candida species: comparison of isolates found in an intensive care unit and in conventional wards.

M Leone1, J Albanèse, F Antonini, A Michel-Nguyen, M-C Blanc-Bimar, C Martin.   

Abstract

The aim of this study was to compare the distribution of Candida species in patients hospitalized in an intensive care unit (ICU) and in conventional wards. A retrospective analysis was performed covering an 18-year period in a 700-bed teaching hospital. Various body sites were investigated in all patients admitted during the study and isolates were identified by microscopic and macroscopic morphology, and by commercially available kits. The susceptibility of strains to amphotericin B and flucytosine was assessed by the ATB-fungus system, itraconazole and fluconazole by Etest. No difference was observed between the distribution of Candida species in ICU and in conventional wards. Candida albicans represented about 70% of isolates and Candida glabrata was the second most common species involved in infection or colonization. The small number of C. glabrata resistant to fluconazole suggested this antifungal agent as suitable empirical treatment for non-immunocompromized patients in whom a fungal infection was suspected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14572482     DOI: 10.1016/j.jhin.2003.07.003

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.

Authors:  M A Pfaller; L Boyken; S A Messer; S Tendolkar; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.

Authors:  Michael A Pfaller; Gary J Moet; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 3.  Nosocomial infections in neurocritical care.

Authors:  Rafael Ortiz; Kiwon Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

4.  Candida isolation in patients hospitalized on a surgical ward: significance and mortality-related factors.

Authors:  J Marchena-Gomez; T Saez-Guzman; M Hemmersbach-Miller; A Conde-Martel; V Morales-Leon; A Bordes-Benitez; M A Acosta-Merida
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.